News | Point-of-Care Ultrasound (POCUS) | October 08, 2020

Butterfly Network Releases New Version of Point-of-Care Ultrasound Platform With Butterfly iQ+

Using ultrasound-on-chip technology the system turns a smartphone into a whole-body diagnostic imaging system

Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) technology that can turn a smartphone into a diagnostic imaging system. It offers a new needle guidance app.

Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) technology that can turn a smartphone into a diagnostic imaging system. It offers a new needle guidance app.

October 8, 2020 – Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) technology that can turn a smartphone into a diagnostic imaging system.

Using ultrasound-on-chip technology, the Butterfly iQ+ offers new capabilities, such as faster frame rates, Needle Viz technology, a longer battery life and improved durability. 

Butterfly’s mission is to democratize healthcare by making medical imaging accessible to everyone around the world. From underserved communities in the United States, to remote areas around the globe, 4.7 billion people lack access to medical imaging. Putting ultrasound on a chip, Butterfly was able to define a new precedent of affordability by providing a whole-body ultrasound device at $1,999, plus membership. The Butterfly iQ+ will be available for the same price. 

“Two years ago, Butterfly introduced the world's first handheld, single-probe, whole-body ultrasound system. Since then, the device has been used by tens of thousands of medical professionals across the globe with significant clinical, economic and societal impact,” said Laurent Faracci, Butterfly Network’s CEO. “We have collaborated with the Butterfly community of users to define our innovation path. The first result in that journey is the new Butterfly iQ+, a big step forward for point-of-care ultrasound, with our most advanced chip ever and a number of amazing innovations and improvements that our talented team and partners developed.”

Butterfly iQ+ features an optimized manufacturing process in partnership with TSMC, the largest and most advanced dedicated IC foundry in the world. TSMC’s MEMS (microelectromechanical systems) manufacturing technology enables the ultrasound transducer to seamlessly integrate with CMOS (complementary metal-oxide semiconductor) technology. In addition, TSMC possesses manufacturing capacity that can scale to realize Butterfly’s vision of making an ultrasound device as ubiquitous as the stethoscope for the world’s 40 million healthcare providers, the company said.

Butterfly’s innovative product has been shown to be a particularly useful tool during the global COVID-19 (SARS-CoV-2) pandemic due to its lung imaging capabilities, portability and ease of cleaning, as infection control has become increasingly important. Butterfly iQ+ brings a suite of new capabilities that make it even easier to make fast decisions at the bedside. 

“These new capabilities bring us one step closer to realizing the full potential of bedside point-of-care ultrasound as the stethoscope of the future, a true window into the body,” said Dr. John Martin, Butterfly Network’s chief medical officer. 

 

Butterfly iQ+ Offers Faster, Sharper Imaging

With patented on-chip digital micro-beamforming enabling 15% faster frame rates and 60% faster pulse repetition frequency, healthcare providers can see image details in the heart, lungs and bladder with optimized clarity. High-performance shallow imaging capabilities help support fast, confident interventional decision-making, while deep imaging capabilities in the lung and deep cardiac presets allow for sharp details. The Butterfly iQ+ can help healthcare providers save time in their diagnosis and treatment of patients, improving overall patient outcomes.

 

State-of-the-art POCUS Technology Offers New Levels of Control

The cutting-edge Needle Viz technology available on Butterfly iQ+ can provide healthcare professionals with an enhanced ability to see a needle—improving confidence for central line placements, regional nerve blocks and other guided procedures. Additionally, in just four seconds, clinicians can calculate bladder volume automatically using the AI-based Auto Bladder Volume tool, allowing faster decisions at the bedside. 

 

Hand-held Ultrasound Offers More Power and Durability 

The Butterfly iQ+ extends battery life by 20% and scanning time by 100% to help healthcare providers get through their shift. With its durable, anodized aluminum body and replaceable compression- and stomp-tested cable, the Butterfly iQ+ offers military-grade durability to withstand tough shifts, and has been tested to withstand an industry-leading 4-foot drop. This next-generation device has gone through rigorous testing to ensure shock resistance and protection from dust and water damage. 

For more information: www.butterflynetwork.com

Related Content

An example of a CT coronary artery calcium scoring exam showing how each vessel segment is scored to assess a patient's risk for a future heart attack. Example is from Philips Healthcare.

An example of a CT coronary artery calcium scoring exam showing how each vessel segment is scored to assess a patient's risk for a future heart attack. Example is from Philips Healthcare.

News | Cardiac Imaging | September 25, 2020
September 25, 2020 — A study out of University Hospitals (UH) found that removing the cost barrier for coronary arter
Rafael Rivero, M.D., Global Head of Medical Affairs at MSI, said: "The importance of MyoStrain cannot be understated because of the test's immense clinical value and ability to quantify intramyocardial dysfunction across 48 segments of the heart. In a six-heartbeat MRI scan, MyoStrain arms physicians with novel clinical information about a patient's heart health."
News | Cardiac Imaging | August 11, 2020
August 11, 2020 — Myocardial Solutions, Inc. and United Imaging, Inc.
The Mindways Solid phantom with volume of interest in the quality assurance phantom (red circles, left side). A participant's noncontrast-enhanced axial CT (right side) with volume of interest (yellow circles) in the trabecular bone compartment of three vertebrae for bone mineral density measurements. Image courtesy of Radiological Society of North America

The Mindways Solid phantom with volume of interest in the quality assurance phantom (red circles, left side). A participant's noncontrast-enhanced axial CT (right side) with volume of interest (yellow circles) in the trabecular bone compartment of three vertebrae for bone mineral density measurements. Image courtesy of Radiological Society of North America

News | Cardiac Imaging | July 15, 2020
July 15, 2020 — ...
Cardiac MR can offer data above and beyond anatomical imaging, which is the main reason why this system was installed at Baylor Scott White Heart Hospital in Dallas. The system is a dedicated heart MRI scanner.

Cardiac MR can offer data above and beyond anatomical imaging, which is the main reason why this system was installed at Baylor Scott White Heart Hospital in Dallas. The system is a dedicated heart MRI scanner.

News | Cardiac Imaging | June 29, 2020
June 29, 2020 — A type of smart magnetic r...
New Multimodality Cardiac Imaging Guidelines for Competitive Athletes Created. ASE SCCT and SCMR recommendations for imaging, screening atheletes.
News | Cardiac Imaging | May 11, 2020
May 11, 2020 – Competitive athletes are a rapidly growing population worldwide.
Figure 4 for the study. Images of a 65-year-old man (patient 6). (a) Cardiac MRI perfusion shows perfusion deficit of anterior/anterolateral wall attributed to left anterior descending artery/left circumflex artery (*). (b) CT coronary angiography. (c) Coronary angiography, left anterior oblique projection with caudal angulation. (d) Three-dimensional image fusion helped refine diagnosis: perfusion deficits (*) were most likely caused by narrow first diagonal branch and its first, stented side branch (arrow

Figure 4 for the study. Images of a 65-year-old man (patient 6). (a) Cardiac MRI perfusion shows perfusion deficit of anterior/anterolateral wall attributed to left anterior descending artery/left circumflex artery (*). (b) CT coronary angiography. (c) Coronary angiography, left anterior oblique projection with caudal angulation. (d) Three-dimensional image fusion helped refine diagnosis: perfusion deficits (*) were most likely caused by narrow first diagonal branch and its first, stented side branch (arrowhead). Retrospectively, denoted lesion could also be found at CT coronary angiography and coronary angiography (arrowheads in b and c, respectively). CT FFR = CT-derived fractional flow reserve, LGE = late gadolinium enhancement. Image courtesy of RSNA, Radiology.

News | Cardiac Imaging | May 04, 2020
May 4, 2020 – A new technique that combines computed tomography (CT) and magnetic resonance imaging MRI can bolster c
An example of a coronary computed tomography angiography (CCTA) exam. The CIAO study looked at patients who have a problem of blood flow limitation and chest pain symptoms in the absence of a 50 percent or more artery narrowing, known as ischemia with no obstructive CAD, or INOCA.

An example of a coronary computed tomography angiography (CCTA) exam. The CIAO study looked at patients who have a problem of blood flow limitation and chest pain symptoms in the absence of a 50 percent or more artery narrowing, known as ischemia with no obstructive CAD, or INOCA.

News | Cardiac Imaging | April 03, 2020
April 3, 2020 — Patients who experience chest pain and have abnormal results on a cardiac stress test but who do not
Schematic depiction of the automated process for assessing fat, muscle, liver, aortic calcification, and bone from original abdominal CT scan data

Figure 1: Depiction of the fully automated CT biomarkers tools used in this study. (A) Schematic depiction of the automated process for assessing fat, muscle, liver, aortic calcification, and bone from original abdominal CT scan data. (B) Case example in an asymptomatic 52-year-old man undergoing CT for colorectal cancer screening. At the time of CT screening, he had a body-mass index of 27·3 and Framingham risk score of 5% (low risk). However, several CT-based metabolic markers were indicative of underlying disease. Multivariate Cox model prediction based on these three CT-based results put the risk of cardiovascular event at 19% within 2 years, at 40% within 5 years, and at 67% within 10 years, and the risk of death at 4% within 2 years, 11% within 5 years, and 27% within 10 years. At longitudinal clinical follow-up, the patient suffered an acute myocardial infarction 3 years after this initial CT and died 12 years after CT at the age of 64 years. (C) Contrast-enhanced CT performed 7 months before death for minor trauma was interpreted as negative but does show significant progression of vascular calcification, visceral fat, and hepatic steatosis. HU=Hounsfield units.

News | Cardiac Imaging | March 06, 2020
March 6, 2020 — Researchers at the National Institutes of Health a